Turning Information
... into Knowledge
Our Solutions Semantic Technologies Support Partners About
Cross-lingual Similarity search Linguistic database Installation time Training/Support Sources and formats Volume/Performance Security and privacy System environment Informational standards USPs/demo version
Contact English Deutsch Franšais


What are the security and privacy features in InfoCodex?

The security gaps and the lack of privacy protection is a well-known weakness of search engines that were originally developed for the Internet at a time when such features were neither required nor widely available (see, e.g. Gartner Research, 13 Mar 2006).

Today, anyone using an enterprise search engine should access only those documents for which he has the necessary access rights of the underlying network ("File system security"). Often, however, this requirement is not always met - even if the supplier claims to have a "sophisticated security system." It might happen that the access rights of some files must be changed by the system administrator or by a user (e.g. because a search engine has displayed search results to unauthorized users). In such cases, the enterprise search engine should react immediately to the modified access rights. InfoCodex is one of the very few systems supporting this feature.

To ensure safe handling of highly sensitive data and privacy, InfoCodex has additional means through creating protected sub-domains for which only selected users/groups own the full sovereign rights. Even system administrators have no access rights to the search and viewing functions in those protected sub-domains.


26. - 27.09.2016 Keynote at Big Data Analytics and Data Mining, London

14.03.16 WebPlatform Ares4 with InfoCodex presented at CeBIT 2016 Hannover

16.09.15 Presentation at SEMANTICS Vienna 2015 "Scientific Discovery by Machine ..." (Session 1.4)

02.06.2015 Presentation at Swiss Competitive Intelligence

26.02.13 Semantic Tech Turns up Biomarkers

13.02.13 Discovery of Novel Biomarkers (joint paper with Merck & Co)